Actually, the cerebrospinal fluid/serum insulin ratio was reported to be reduced in both type 2 diabetes and Alzheimer’s disease [8, 9], and intranasal-delivered insulin improved cognitive function in a patient with diabetes without changing serum glucose level [10, 11], supporting the suggestion that insulin resistance induced cognitive decline. This evidence concerns the gene INS and early-onset autosomal dominant Alzheimer disease.